These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29425238)

  • 1. Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles.
    Zhang N; Zoltner M; Leung KF; Scullion P; Hutchinson S; Del Pino RC; Vincent IM; Zhang YK; Freund YR; Alley MRK; Jacobs RT; Read KD; Barrett MP; Horn D; Field MC
    PLoS Pathog; 2018 Feb; 14(2):e1006850. PubMed ID: 29425238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs.
    Giordani F; Paape D; Vincent IM; Pountain AW; Fernández-Cortés F; Rico E; Zhang N; Morrison LJ; Freund Y; Witty MJ; Peter R; Edwards DY; Wilkes JM; van der Hooft JJJ; Regnault C; Read KD; Horn D; Field MC; Barrett MP
    PLoS Pathog; 2020 Nov; 16(11):e1008932. PubMed ID: 33141865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.
    Wall RJ; Rico E; Lukac I; Zuccotto F; Elg S; Gilbert IH; Freund Y; Alley MRK; Field MC; Wyllie S; Horn D
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9616-9621. PubMed ID: 30185555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
    Hall BS; Meredith EL; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5821-30. PubMed ID: 22948871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
    Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
    J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Antiplasmodial 2-Aminopyridines as Potential Antitrypanosomal Agents.
    Veale CGL; Laming D; Swart T; Chibale K; Hoppe HC
    ChemMedChem; 2019 Dec; 14(24):2034-2041. PubMed ID: 31670464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
    Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
    J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.
    Hall BS; Wu X; Hu L; Wilkinson SR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1193-9. PubMed ID: 20028822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors.
    Xin W; Li Z; Wang Q; Du J; Zhu M; Zhou H
    Eur J Med Chem; 2020 Jan; 185():111827. PubMed ID: 31732256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds.
    Ruda GF; Wong PE; Alibu VP; Norval S; Read KD; Barrett MP; Gilbert IH
    J Med Chem; 2010 Aug; 53(16):6071-8. PubMed ID: 20666371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
    Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP
    J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
    Wilkinson SR; Bot C; Kelly JM; Hall BS
    Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.
    Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH
    Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.
    Hall BS; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Jan; 56(1):115-23. PubMed ID: 22037852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.